An implantable medical device includes a polymer substrate and at least one nanofiber. The polymer substrate includes a surface portion extending into the polymer substrate from a surface of the substrate. The at least one nanofiber includes a first portion and a second portion. The first portion is interpenetrated with the surface portion of the substrate, and mechanically fixed to the substrate. The second portion projects from the surface of the substrate.

A method and related system for treating a metallic surface in order to eradicate bacteria on the metallic surface using at least three electrodes and in which the metallic surface is one of the electrodes and in which a stimulation voltage is applied to the metallic surface and an accumulated charge is measured. The accumulated charge is compared to a threshold level wherein the stimulation voltage is maintained until the accumulated charge exceeds the threshold level. In at least one version, the metallic surface is that of a surgical implant.

A total hip surface replacement implant, comprising a femur component and an acetabular cup component, wherein the femur component is in a half-spherical shell shape and is formed by polyether ether ketone (PEEK) or derivatives thereof; the shape of the acetabular cup component matches that of the femur component, and the acetabular cup component is tightly attached to an outer surface of the half-spherical shell of the femur component; the acetabular cup component is formed by ultrahigh molecular weight polyethylene; or the femur component can be formed by ultrahigh molecular weight polyethylene, and meanwhile the acetabular cup component is formed by polyether ether ketone (PEEK) or derivatives thereof. The total hip surface replacement implant employs friction combination between organic polymers so as to reduce material toxicity against a living body; the rigidity of the organic polymers more matches that of a natural bone of a human body, thereby reducing implant wearing in a usage process; and by means of an optimization design of a positioning column on a femur condyle, the clinic problems of early neck-of-femur fracture and medium-and-long term bone resorption are avoided.

A total hip surface replacement implant, comprising a femur component and an acetabular cup component, wherein the femur component is in a half-spherical shell shape and is formed by polyether ether ketone (PEEK) or derivatives thereof; the shape of the acetabular cup component matches that of the femur component, and the acetabular cup component is tightly attached to an outer surface of the half-spherical shell of the femur component; the acetabular cup component is formed by ultrahigh molecular weight polyethylene; or the femur component can be formed by ultrahigh molecular weight polyethylene, and meanwhile the acetabular cup component is formed by polyether ether ketone (PEEK) or derivatives thereof. The total hip surface replacement implant employs friction combination between organic polymers so as to reduce material toxicity against a living body; the rigidity of the organic polymers more matches that of a natural bone of a human body, thereby reducing implant wearing in a usage process; and by means of an optimization design of a positioning column on a femur condyle, the clinic problems of early neck-of-femur fracture and medium-and-long term bone resorption are avoided.

Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween. The impregnating liquid fills spaces between said solid features, the surface stably contains the impregnating liquid between the solid features, and the impregnating liquid is substantially held in place between the plurality of solid features regardless of orientation of the surface.

Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween. The impregnating liquid fills spaces between said solid features, the surface stably contains the impregnating liquid between the solid features, and the impregnating liquid is substantially held in place between the plurality of solid features regardless of orientation of the surface.

Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection.

In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.

##STR00001##

In one aspect, the invention provides compounds of Formula I Formula Ia, Formula Ib, Formula Ic, and Formula Id and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes bone loss, and cancer, using a compound of Formula I, Formula Ia, Formula Ib, Formula Ic, or Formula Id.

##STR00001##

Embodiments herein include coated medical devices and coatings with salt groups. In an embodiment, a coated medical device is included, the coated medical device including a substrate and a polymeric layer disposed over the substrate. The polymeric layer includes a polymer and has an exterior surface. The coated medical device further includes a plurality of salt groups bonded to the polymer of the polymeric layer and disposed on the exterior surface of the polymeric layer. The salt groups can be the reaction product of a reactive group with an acid or base. In an embodiment, a method of making a medical device is included. Other embodiments are also included herein.